Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India
· Delayed Price · Currency is INR 2,425.00
+21.30 (0.89%)
Apr 29, 2026, 11:50 AM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 678.33 billion as of April 28, 2026. Its market cap has increased by 55.56% in one year.
Market Cap
678.33B
Enterprise Value
663.66B
Revenue
165.10B
Ranking
n/a
PE Ratio
63.69
Stock Price
2,425.00
Market Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 678.33B, an increase of 58,920.64%. That is a compound annual growth rate of 29.20%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 638.96B |
| Laurus Labs | 606.56B |
| Aurobindo Pharma | 822.82B |
| Mankind Pharma | 936.58B |
| Zydus Lifesciences | 945.51B |
| Cipla | 1,064.01B |
| Ipca Laboratories | 391.03B |
| Ajanta Pharma | 350.58B |